← Issue №9/ week of Aug 30, 2026/Endoscopy

Post-Endoscopy Upper Gastrointestinal Cancer in a United States Multicenter Cohort: Site- and Risk-Stratified Trends and Survival.

From GI Signals issue №9: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Endoscopy retrospective · n=14,814 · Aug 28, 2026 · Endoscopy · IF 11.8

Post-Endoscopy Upper Gastrointestinal Cancer in a United States Multicenter Cohort: Site- and Risk-Stratified Trends and Survival.

New evidenceepidemiologyendoscopy qualityhealth services
Clinical takeawayConsider HRCs (specific criteria not detailed in abstract) when auditing endoscopy quality; PEUGIC rates are 3.6-fold higher with HRCs compared to without HRCs. Site-specific benchmarks may better reflect performance than aggregate metrics.
What it foundPost-endoscopy upper GI cancer (PEUGIC) rate was 9.4% overall, higher with high-risk conditions (HRCs) (18.2%) vs without HRCs (5.0%), and varied by site (esophageal 9.6%, gastric 8.6%, duodenal 10.7%).
ContextConfirms PEUGIC as a significant quality gap, with rates stable in low-risk patients but improving in high-risk esophageal and gastric cancer over time. Challenges one-size-fits-all benchmarking.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Fakhoury B … Desai M · Endoscopy · IF 11.8 · PubMed ↗Permalink
← Read the whole of issue №9 Every paper GI Signals surfaces gets a page like this one. All issues